NRx Pharmaceuticals, Inc. announced the date for its annual meeting of stockholders, the '2025 Annual Meeting'.
The record date for the meeting is set for February 12, 2026.
Details regarding the agenda and timing of the meeting will be provided in the upcoming proxy statement to be filed with the SEC.
Annual Meeting Details
2025 Annual Meeting to be held virtually on March 23, 2026 at 10:00 a.m. Eastern Time.
Record Date
February 12, 2026 is the record date for stockholders entitled to notice and vote at the meeting.
Submission Deadline
Stockholder proposals and nominations deadline is January 26, 2026.
- Stockholders must adhere to specific guidelines to submit proposals or nominations for the meeting.
- The announcement provides clarity on important dates and procedures for shareholders to engage with the Company.
The disclosure of the 2025 Annual Meeting date and related deadlines offers transparency and ensures proper shareholder engagement. NRx Pharmaceuticals continues to focus on developing therapeutics in the field of central nervous system disorders.